{"schema_version":"secwatch.filing_event.v1","accession":"0001932393-26-000045","form_type":"8-K","ticker":"GEHC","cik":"0001932393","company_name":"GE HealthCare Technologies Inc.","filed_at":"2026-07-29T10:25:46+00:00","discovered_at":"2026-07-29T10:30:00.277695+00:00","generated_at":"2026-07-29T10:30:10.162602+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"GE HealthCare Q2 revenue up 5.7% to $5.3B; EPS $1.24; reaffirms FY guidance","bullets":["Revenue $5.3B (+5.7% YoY); organic revenue +3.5%; net income $561M vs $486M.","Diluted EPS $1.24 (+16.5%); adjusted EPS $1.13 (+6.6%).","Record organic orders growth 11.1%, book-to-bill 1.15x, backlog $23.9B.","Patient Care Solutions revenue -13.3%, EBIT -$26M; CEO reviewing strategic options.","Reaffirms FY2026 guidance: organic rev growth 3-4%, adj EPS $4.80-$5.00, FCF ~$1.6B."],"urls":{"canonical":"https://secwatch.observer/filing/0001932393-26-000045","json":"https://secwatch.observer/filing/0001932393-26-000045.json","markdown":"https://secwatch.observer/filing/0001932393-26-000045.md","text":"https://secwatch.observer/filing/0001932393-26-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1932393/000193239326000045/0001932393-26-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1932393/000193239326000045/gehc-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T10:30:10.162602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}